SC 13D/A

AMENDMENT NO. 1 TO THE SCHEDULE 13D

Company: Olema Pharmaceuticals, Inc.
Filed: December 2, 2021
Accession Number: 0001193805-21-001680

View Document ↗ View on SEC.gov ↗